RxDoctor Payments Data

Jonathan Trujillo, MD

Hematology & Oncology · Chicago, ILNPI 1801205208

Payments from drug & device makers

What this record shows

That places this record below the midpoint for hematology & oncology clinicians in IL, where the typical reported total is $2,365.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$1,268,119in research payments, 2019–2025

Across 7 payments — averaging $181,160 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$1.3M

How this compares

$0 in reported general payments places this provider in the 0th percentile of 580 hematology & oncology providers in Illinois.

See all hematology & oncology providers in Illinois

Medicare billing

Part B allowed, 2024
$16,403
Medicare patients
51
Services billed
130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide37$492,990
NubeqaDarolutamide13$156,068
OrgovyxRelugolix19$47,613
Abiraterone Acetate85$29,289
Prednisone136$434

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →